Irvine, California – November 03, 2026 -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), will present nine abstracts at the 2026 American Society for Dermatologic Surgery (ASDS) Annual Meeting, Nov. 5-8 in San Diego, including new data from two Phase 4 studies on aesthetic treatment in patients taking GLP-1-related medications for weight management.